Researcher Fired Over Cell Fiasco
By Associated Press,
Associated Press
| 03. 21. 2006
SEOUL _ The scientist who stunned the medical world with claims that he had created the first cloned human embryos and extracted stem cells from them _ research later found to have been faked _ was fired Monday by South Korea's most prestigious university.
Seoul National University decided to dismiss Hwang Woo-suk after a disciplinary meeting, saying he and his co-workers caused the school to lose honor. Six other professors who worked with Hwang were either suspended or had their salaries cut, the school said.
Last month, the school suspended Hwang, 53, from teaching and conducting research as an interim disciplinary measure, but he had remained a professor.
"The professors fundamentally abandoned honesty and sincerity _ and caused the fall in the school's honor and the country's international confidence," the university said in a statement Monday.
Byun Chang-ku, dean of the school's academic affairs, said the committee had decided to fire Hwang because he "took overall responsibility as the lead author and played a leading role in writing the papers with fake facts and data."
Hwang rarely appears in public...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
